Results 241 to 250 of about 423,879 (287)
Some of the next articles are maybe not open access.
Adherence and persistence to urate-lowering therapies in the Irish setting
Clinical Rheumatology, 2014To identify adherence and persistence levels with urate-lowering therapies using the national administrative pharmacy claim database. This was a retrospective, pharmacy claims-based analysis of dispensed anti-gout medications on the Irish national HSE-PCRS scheme database between January 2008 and December 2012.
Bernie, McGowan +3 more
openaire +2 more sources
Influence of urate-lowering therapies on renal handling of uric acid
Clinical Rheumatology, 2014The purpose of this study is to investigate the effect of urate-lowering therapies (ULTs) on renal uric acid excretion in gout patients. This prospective observational study involved 106 primary gout patients and 51 healthy controls. Gout patients received ULT with either xanthine oxidase inhibitors or the uricosuric agent benzbromarone.
Lili, Ma +6 more
openaire +2 more sources
Ultrasound in gout: A useful tool for following urate-lowering therapy
Joint Bone Spine, 2015We aimed to determine the ability of ultrasonography (US) to show decrease or disappearance of urate deposits in gouty patients requiring urate-lowering therapy (ULT).To be included in this prospective single-centre study, patients needed toexhibit (1) proven gout by monosodic urate (MSU) crystals in synovial fluid and (2) US-evidenced urate deposits ...
Sébastien, Ottaviani +5 more
openaire +2 more sources
Pharmacist-managed titration of urate-lowering therapy to streamline gout management
Rheumatology International, 2019The treat-to-target approach for serum uric acid is the recommended model in gout management according to the 2012 American College of Rheumatology (ACR) guidelines. Adherence to urate-lowering therapy (ULT) can be difficult for patients due to barriers, which include medication burden, financial hardship, and lack of medical literacy.
Irvin J. Huang +5 more
openaire +2 more sources
Gradual reduction of tophaceous deposits during urate-lowering therapy
Joint Bone Spine, 2021Sara Nysom Christiansen +3 more
openaire +3 more sources
Benefits of urate-lowering therapy in asymptomatic hyperuricemia
Evidence-Based Practice, 2022Alexandria Cooke, Hannah King
openaire +1 more source
Initiation of Urate Lowering Therapy (ULT)
The Singapore Family Physician, 2022openaire +1 more source
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
Initiation of Urate Lowering Therapy (ULT)
The Singapore Family Physician, 2021openaire +1 more source